Home/SEC 13D/G/RNTXSEC 13D/GRNTX - Rein Therapeutics Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks Simplified$RNTX$0.82▼ -11.83% YTDHealthcareAug 14, 2026 · ThinkSabio BlogSEC Filing Update: #RNTX Rein Therapeutics Inc. : $0.82 Sector: Healthcare | YTD: 🔽 -11.83% The SEC disclosed Today (14-AUG-2026) that Lynwood Capital Management Inc. has DECREASED #RNTX Shares by -9.88% 🔴 * Previous Holdings: 4.75M Shares * Current Holdings: 4.28M Shares * Decrease -469.50K * Decreased (%)-9.88% * Ownership: 5.0% https://www.thinksabio.com/reports/isr/RNTX Institutional ownership in #RNTX has been steadily rising over the past 7 quarters in Shares: Q3 2024: 4.61M Q4 2024: 5.68M Q1 2025: 6.02M Q2 2025: 6.66M Q3 2025: 8.49M Q4 2025: 10.80M Q1 2026: 11.40M Share this post🔗Copy LinkMore filings for $RNTXRNTX - Rein Therapeutics Inc. - SEC Filing Update (13-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 13, 2026$RNTX SEC Filing Update (14-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 14, 2026💬 Comments Loading comments…Leave a commentPost Comment← All PostsMore SEC 13D/G